MEG and Aphantasia
Condition(s) studied
Investigational drug(s) / intervention(s)
MEG: Within a single session, measure of brain oscillations during four types of covert actions (motor imagery, action observation, action language and movement preparation).
MRI: Anatomical MRI, performed once
Vividness of motor imagery questionnaire - second version: Before MEG and MRI, measure of vividness for internal visual imagery, external visual imagery and kinesthetic imagery (for 12 actions).
Study summary
Covert actions are cognitive processes that involves the motor system. They include motor imagery, movement preparation, action observation or action language. They imply mental simulations, based on activations of neural networks, involved in specific operations such as perceiving or acting. These mental phenomena have intrigued and still intrigue philosophers, psychologists, and neuroscientists, as they are complex and introspective processes, which play a major role in human cognition.
To decipher similarities and differences between these types of covert actions, the investigators will focus on persons living with aphantasia, which is a neurocognitive specificity present in a small proportion of the population (5 to 8%). Aphantasia is characterized by the alteration or the absence of explicit mental representations.
This population offers an ideal testbed to disentangle the involvement of cognitive and motor processes in different forms of covert actions.
By means of magnetoencephalography, this study aims to identify and compare brain patterns and their temporal dynamics in alpha and beta bands during covert actions in two groups of healthy volunteers: aphantasics and non-aphantasics (i.e., having a non-altered imagery capacity).
If covert actions indeed share brain networks, the investigators expect aphantasics to present reduced neural and behavioral activation during the explicit (i.e., motor imagery) and implicit (movement preparation, action language and action observation) forms of covert actions.
Eligibility
Primary outcome measure(s)
- Whole-brain power of beta band (Tesla2) — During MEG recording
Power of beta band with whole brain analysis during each of the four covert actions (motor imagery, action observation, movement preparation and action language).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CERMEP | Bron | France |
More Hospices Civils de Lyon trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07630324 on ClinicalTrials.gov ↗ ← All trials in France